Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs
July 26, 2024 Comments Off
The results come as Bristol Myers moves to cut $1.5 billion in costs by 2025 and reinvest that money into key drug brands and research and development programs.
Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs
The results come as Bristol Myers moves to cut $1.5 billion in costs by 2025 and reinvest that money into key drug brands and research and development programs.
Archives
Categories
Archives
Recent Posts
Meta
Categories
Calender